---
title: How Trust and Collaboration Drive Inclusive Clinical Research
description: Trust and collaboration fuel inclusive clinical research. Learn how Acclinate’s partnerships turn shared purpose into lasting impact.
image: https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/partnership1.jpg
---

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
    - [eDICT](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros)
    - [Partners](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [About Us](https://www.acclinate.com/about)
    - [Careers](https://www.acclinate.com/careers)
    - [News](https://news.acclinate.com)
- Resources 
    - [Resource Library](https://www.acclinate.com/resources)
    - [Blog](https://blog.acclinate.com)
    - [Press Kit](https://www.acclinate.com/press-kit)
    - [Events](https://www.acclinate.com/events)
    - [Glossary](https://www.acclinate.com/glossary)
    - [FAQ](https://www.acclinate.com/faq)
- [Talk to Our Team](https://info.acclinate.com/get-in-touch)

[![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302)

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [**NOWINCLUDED**Acclinate’s B2C community platform
      
      ](https://www.acclinate.com/products/nowincluded-the-community)
    - [**e-DICT**Acclinate’s patented AI-powered technology
      
      ](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials.
      
      ](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines.
      
      ](https://www.acclinate.com/solutions/for-cros)
    - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve.
      
      ](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation.
      
      ](https://www.acclinate.com/about)
    - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation.
      
      ](https://www.acclinate.com/careers)
- Resources 
    - [**Resources Hub**
      
      ](https://www.acclinate.com/resources)
    - [**Glossary**
      
      ](https://www.acclinate.com/glossary)
    - [**Press Kit**
      
      ](https://www.acclinate.com/press-kit)
    - [**Events**
      
      ](https://www.acclinate.com/events)
    - [**Blog**
      
      ](https://blog.acclinate.com/)
    - [**News**
      
      ](https://news.acclinate.com/)
    - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png)
      
      **FAQs**
      
      ](https://www.acclinate.com/faq)
- [ Contact Us ](https://www.acclinate.com/contact-us)

Stay up to date

 Get news directly in your inbox

Topic

 All

- [Affective Trust ](https://blog.acclinate.com/tag/affective-trust)
- [Announcement ](https://blog.acclinate.com/tag/announcement)
- [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software)
- [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies)
- [Community ](https://blog.acclinate.com/tag/community)
- [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials)
- [e-DICT™ ](https://blog.acclinate.com/tag/e-dict)
- [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan)
- [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials)
- [Health Equity ](https://blog.acclinate.com/tag/health-equity)
- [Partnerships ](https://blog.acclinate.com/tag/partnerships)
- [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare)

[Affective Trust](https://blog.acclinate.com/topic/affective-trust)

# Partnering for Progress: How Trust and Collaboration Drive Inclusive Clinical Research

 Trust and collaboration fuel inclusive clinical research. Learn how Acclinate’s partnerships turn shared purpose into lasting impact.

![Partnering for Progress: How Trust and Collaboration Drive Inclusive Clinical Research](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/partnership1.jpg)

 Clinical Trial Diversity: What Does It Really Mean?

 Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t...

Read More 

<https://blog.acclinate.com/partnering-for-progress-how-trust-and-collaboration-drive-inclusive-clinical-research#>

![ Willow MacDonald](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/1734451855401.jpg)

[Willow MacDonald](https://blog.acclinate.com/author/willow-macdonald)

 Customer Success Lead, Acclinate

 Share this Post:

[**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/partnering-for-progress-how-trust-and-collaboration-drive-inclusive-clinical-research) [**](https://twitter.com/home?status=https://blog.acclinate.com/partnering-for-progress-how-trust-and-collaboration-drive-inclusive-clinical-research) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/partnering-for-progress-how-trust-and-collaboration-drive-inclusive-clinical-research&title=How%20Trust%20and%20Collaboration%20Drive%20Inclusive%20Clinical%20Research)

Stay up to date

 Get news directly in your inbox

Trust forms the foundation of everything we do at Acclinate. For me, building sustainable, non-transactional relationships is a key ingredient in cultivating that trust. When a customer chooses to partner with us, they’re aligning with a mission that extends beyond project deliverables. Together, we work to accelerate health advancements for all communities, while making clinical research more inclusive and equitable.

That purpose gives my role in Customer Success a deep sense of meaning. Every day, my team acts as the bridge between our customers’ goals and Acclinate’s mission. We translate shared purpose into measurable outcomes that strengthen both research and relationships.

Our work requires more than timelines and tasks. Trust, accountability, and excellence must be felt in every interaction. To sustain that standard, we’ve built our approach around something simple yet effective: being the partner our customers choose first and trust most. 

## **The Partner-of-Choice Mindset** 

Being a *partner of choice* means taking full ownership of the relationship. It takes showing up as a reliable, forward-thinking collaborator who understands the customer’s goals as well as they do.

Our Customer Success team practices this mindset by staying ahead of needs. We don’t wait for an email to point out an issue. We look for opportunities and risks before they appear. We deliver insights that help our customers make informed decisions, adjust timelines, and strengthen outcomes. Every proactive step reinforces trust and makes collaboration more efficient.

We also act as our customers’ internal advocates. When we see ways to improve a product, clarify a process, or expand functionality, we share that feedback across Acclinate’s teams. Their voices help shape our evolution as a company. That feedback loop—listening, improving, and responding—is how we grow alongside the people we serve.

[![Download Now – Achieving Affective Trust: Actionable Insights Into Advancing Health Equity](https://no-cache.hubspot.com/cta/default/19943632/interactive-193539504024.png) ](https://blog.acclinate.com/hs/cta/wi/redirect?encryptedPayload=AVxigLJog79UsWEsBv9n4dGqtdoaxKTgABvVOF1QBqwXA%2FKONBLNkGj%2BF2ar6%2B3KdMzicdQfll%2FVPVv2pgXcEf5Jy%2F%2FOX0p0PLxzk3Y%2Frmj7NcUjeeqRbQi048NOkdRhgg9V1yF0xdv%2F13F%2FvIVbGXOL%2BdFudsQmHo%2BtyDifgRV6HDF%2FmKw10FqnKxeSpaJiTDp3Gro7%2Bf%2ByNmxEiu0iJKydoZdWjh4zF6Hyj3HFCq5hyQZ%2BcborOQ%3D%3D&webInteractiveContentId=193539504024&portalId=19943632)

As a small, tightly connected team, we have a distinct advantage: we can move fast without losing precision. Many of our customers work within large organizations where every adjustment requires multiple approvals. Our ability to act quickly while maintaining quality gives partners flexibility and momentum. It’s what allows us to serve as a true extension of their teams, operating at a pace that makes progress feel possible.

And while reliability keeps partnerships steady, trust is what deepens them. That’s where everything we do begins—and grows.

## **The Currency of Trust in Clinical Research Partnerships ** 

[Trust is the foundation of any long-term success.](https://blog.acclinate.com/overcome-clinical-trial-recruitment-challenges-start-with-affective-trust) When I first joined Acclinate, I worked with a major pharmaceutical partner whose next steps were unclear. Instead of focusing on scope or revenue, I focused on building connection. I listened, asked questions, and worked to understand the challenges they faced within their own organization.

That consistent communication built alignment, and alignment turned into trust. Together, we identified ways to leverage their existing systems and workflows to meet and then surpass our initial goals. What started as a single engagement has since expanded into five additional clinical studies, each one rooted in mutual respect and a shared commitment to results.

What I’ve learned through that process is simple: when customers feel heard and supported, they’re far more willing to innovate. Trust creates the conditions for better problem-solving and more creative collaboration. It’s the foundation for every meaningful success story we’ve had since.

Of course, even the strongest relationships face challenges. How we respond in those moments often determines how enduring that trust truly is.

**[Ready to learn more about our partnerships? Explore our case studies.](https://www.acclinate.com/case-studies)**

## Excellence Under Pressure

Excellence shines brightest when the situation is difficult. In clinical research, variables shift constantly—timelines change, data delays occur, and new priorities emerge overnight. These moments test the relationship, but they also reveal its strength.

When challenges arise, our team begins by clarifying what happened and why. We assemble the right expertise, design a clear action plan, and stay in close contact with the customer until the issue is resolved. That combination of transparency and discipline keeps the partnership steady, even during uncertainty.

Excellence under pressure doesn’t mean being perfect, but rather being reliable. When customers see us navigate challenges with composure and accountability, their confidence in Acclinate grows stronger. They know that even when the work gets complex, we’ll remain focused on their success.

That same focus carries us into the next phase of every partnership—sustaining what we’ve built and continually improving together.

## **Sustaining Success Through Co-Creation ** 

Enduring success depends on growing with our customers, not just serving them. The most impactful outcomes happen when both sides are invested fully in creating solutions together. We collaborate closely to align on metrics, refine strategies, and adapt our approach based on what’s working in real time.

We’re also intentional about how we communicate results. Many of our partners must demonstrate value internally, so we make sure every report or presentation is easy to share and clearly tells the story of our joint impact. From performance summaries to data visualizations, we want our customers to feel confident showcasing the work we’ve accomplished together.

That attention to clarity lightens their workload and builds long-term trust. When they can demonstrate measurable outcomes to their own stakeholders, our partnership becomes a source of pride, not just another vendor relationship. It’s gratifying to know that what we deliver doesn’t just help our partners meet goals—it strengthens their credibility across their organization.

When the relationship runs smoothly, it also allows their teams to focus on their core mission: advancing research that reflects every community and improves outcomes for all.

This alignment—between purpose, process, and progress—is what transforms partnerships from projects into long-term commitments.

## **Beyond Retention: Aligning on Shared Healthcare Research Goals** 

Our multi-year partnerships—such as our [collaboration with a major multiple myeloma researcher](https://www.acclinate.com/building-bridges-for-better-health-fostering-health-equity-in-multiple-myeloma-research)—demonstrate how consistency and alignment compound over time. These renewals extend beyond the immediate purview of new projects to embody cycles of growth where we refine, expand, and amplify our impact each year.

When a partnership is built on trust and purpose, attention naturally shifts from immediate outputs to long-term outcomes. Together, we’re building a more inclusive research environment, advancing representation, and helping shape the future of equitable healthcare.

That’s what excites me most about Customer Success at [Acclinate](https://www.acclinate.com): we cultivate alliances that magnify our shared mission and move the entire industry forward. When trust and excellence are treated as ongoing practices—not milestones—the relationship continues to evolve. Every interaction becomes part of something long-lasting.

## **The Legacy of Every Interaction** 

Every customer interaction—whether a quick check-in or a major project milestone—creates a lasting impression. We treat each as a chance to build upon trust, strengthen alignment, and deliver excellence that our customers can feel.

Excellence doesn’t happen by accident. It’s the product of empathy, accountability, and discipline applied consistently over time. At Acclinate, we take pride in being the partner that customers can depend on for clarity, integrity, and meaningful collaboration.

Every relationship leaves a legacy. Ours is defined by trust, performance, and a commitment to making clinical research more inclusive—one partnership, one project, and one interaction at a time.

[Want to see our Customer Success approach in action? Schedule a 1:1 with our team.](https://get.nowincluded.com/cs/c/?cta_guid=06387b94-c49a-4a46-9ace-10df11a46c52&signature=AAH58kFNj3I4RDwZZZQr-vYOGYLxOKQAVA&utm_referrer=https%3A%2F%2Fblog.acclinate.com%2Fovercome-clinical-trial-recruitment-challenges-start-with-affective-trust&portal_id=19943632&placement_guid=31583cc4-4449-4d4b-8cb9-94b6615b6eee&click=7a0cccd0-5937-4adc-89a4-da63c898d438&redirect_url=APefjpF4ThqwLf6s3M0POLd7Gh_u4nmGv_eqlgSRJXyzMXy3f_atRC57dSLGLPJ1CbSCO_0IeOy9ZibCohOB8UGIYakC3oXEkx18I8TLQIwlv8qPvPBTHuK4hpyRZwrRe9p1BTFjilLG3B9JAK8ELmh7NUV33o6AjxpQZRA0_0LTkyY3GqFUZ9dFFHdUdwIOEUJY0ex99Oj2vzDcg2S2fFgr06Ak51-LGc5qREZABAJ4-YpzhB2YNVif7Og2ek2thBTwbcPSWHysM6jxovJmjLr1ZF5NqJNE3g&hsutk=af2d6b60f434b25264f6c24b1b4bd070&canon=https%3A%2F%2Fwww.acclinate.com%2Fcase-studies&ts=1760122127950&__hstc=268225873.af2d6b60f434b25264f6c24b1b4bd070.1751404298255.1759276883949.1760122050108.37&__hssc=268225873.6.1760122050108&__hsfp=3311438139)

[![Achieving Affective Trust:Actionable Insights IntoAdvancing Health Equity](https://no-cache.hubspot.com/cta/default/19943632/2daa6753-37c3-421c-a858-ea4e51d5f618.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2daa6753-37c3-421c-a858-ea4e51d5f618)

## Recent Posts

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) 

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

<https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

 June 25, 2026

 3 Min Read

 Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr...

Read More

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) 

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

<https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

 June 25, 2026

 3 Min Read

 For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle...

Read More

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) 

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

<https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

[ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

 June 25, 2026

 3 Min Read

 Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s...

Read More

[![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) 

](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>[ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

 June 24, 2026

 1 Min Read

 Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h...

Read More

[![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) 

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

<https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

[ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

 March 2, 2026

 3 Min Read

 For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality.

Read More

[![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) 

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

<https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

[ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

 February 16, 2026

 3 Min Read

 Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h...

Read More

[![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) 

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

<https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

[ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

 February 9, 2026

 3 Min Read

 Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical...

Read More

[![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) 

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

<https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

[ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

 February 2, 2026

 2 Min Read

 Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ...

Read More

[![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) 

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

<https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

[ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

 January 26, 2026

 3 Min Read

 Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited...

Read More

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp)

 June 25, 2026 

 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World

Read More

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp)

 June 25, 2026 

 Clinical Trial Generalizability: What Regulators Will Scrutinize Next

Read More

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp)

 June 25, 2026 

 Site Engagement Index (SEI): Measuring What Actually Builds Trust

Read More

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp)

![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp)

![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp)

## Ready to Measure Your True Impact?

 Partner with Acclinate to turn mission into measurable, data-driven action.

[ Get Started ](https://www.acclinate.com/contact-us)

[![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/)

- Products
- [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
- [e-DICT](https://www.acclinate.com/products/e-dict)

- Solutions
- [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
- [CROs](https://www.acclinate.com/solutions/for-cros)
- [Community Partners](https://www.acclinate.com/solutions/community-partners)

- Resources
- [Resources Hub](https://www.acclinate.com/resources)
- [Glossary](https://www.acclinate.com/glossary)
- [Press Kit](https://www.acclinate.com/press-kit)
- [Events](https://www.acclinate.com/events)
- [News](https://news.acclinate.com/)
- [Blog](https://blog.acclinate.com/)
- [FAQs](https://www.acclinate.com/faq)

- Company
- [About us](https://www.acclinate.com/about)
- [Careers](https://www.acclinate.com/careers)
- [Contact Us](https://www.acclinate.com/contact-us)

- Follow Us
- [** Linkedin](https://www.linkedin.com/company/acclinateinc/)

- [Privacy Policy](https://www.acclinate.com/privacy)
- [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Willow MacDonald",
    "url" : "https://blog.acclinate.com/author/willow-macdonald"
  },
  "dateModified" : "2025-11-03T17:29:19.403Z",
  "datePublished" : "2025-10-14T13:15:00.000Z",
  "headline" : "How Trust and Collaboration Drive Inclusive Clinical Research",
  "image" : [ "https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/partnership1.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.acclinate.com/partnering-for-progress-how-trust-and-collaboration-drive-inclusive-clinical-research",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png"
    },
    "name" : "Acclinate"
  }
}
```